These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15284857)

  • 21. Drug-resistant viral hepatitis.
    Wright M; Main J; Thomas HC
    J Infect; 2000 Jul; 41(1):1-4. PubMed ID: 10942634
    [No Abstract]   [Full Text] [Related]  

  • 22. Evaluation of interleukin-8 in hepatitis C virus infection: relation to combined peg-interferon ribavirin response and genotype 4.
    El Sayed ZM; Mansour FA; Ghal MF; Abou-Zahra SB
    Immunol Invest; 2011; 40(1):29-38. PubMed ID: 20809700
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Evaluating the efficacy of interferon therapy on hepatitis C patients].
    Shiraha H; Iwasaki Y; Shiratori Y
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):489-92. PubMed ID: 15359847
    [No Abstract]   [Full Text] [Related]  

  • 24. Frequency of very low HCV viremia detected by a highly sensitive HCV-RNA assay.
    Fytili P; Tiemann C; Wang C; Schulz S; Schaffer S; Manns MP; Wedemeyer H
    J Clin Virol; 2007 Aug; 39(4):308-11. PubMed ID: 17625963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Focus.
    Samuel D
    J Hepatol; 2010 Jan; 52(1):3-4. PubMed ID: 19923033
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of hepatitis C: don't put all your eggs in one basket!
    Pawlotsky JM
    Gastroenterology; 2007 Apr; 132(4):1611-5. PubMed ID: 17418174
    [No Abstract]   [Full Text] [Related]  

  • 27. Successful treatment of membranoproliferative glomerulonephritis associated with hepatitis B and C virus simultaneous infection patient.
    Mima A; Iehara N; Matsubara T; Yamamoto S; Abe H; Nagai K; Matsuura M; Murakami T; Kishi S; Araoka T; Kishi F; Kondo N; Shigeta R; Yoshikawa K; Takahashi T; Kita T; Doi T; Fukatsu A
    Clin Nephrol; 2010 Feb; 73(2):167-9. PubMed ID: 20129026
    [No Abstract]   [Full Text] [Related]  

  • 28. Therapeutics: new drugs hit the target.
    Schlütter J
    Nature; 2011 Jun; 474(7350):S5-7. PubMed ID: 21666733
    [No Abstract]   [Full Text] [Related]  

  • 29. [Hepatitis C virus infection--after 20 years].
    Pár A
    Orv Hetil; 2010 Mar; 151(12):485-93. PubMed ID: 20231132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HCV-associated B-cell non-Hodgkin lymphomas and new direct antiviral agents.
    Carrier P; Jaccard A; Jacques J; Tabouret T; Debette-Gratien M; Abraham J; Mesturoux L; Marquet P; Alain S; Sautereau D; Essig M; Loustaud-Ratti V
    Liver Int; 2015 Oct; 35(10):2222-7. PubMed ID: 26104059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Remission of Follicular Lymphoma after Treatment for Hepatitis C Virus Infection.
    Maciocia N; O'Brien A; Ardeshna K
    N Engl J Med; 2016 Oct; 375(17):1699-1701. PubMed ID: 27783921
    [No Abstract]   [Full Text] [Related]  

  • 32. Response to peginterferon treatment in hepatitis C virus-associated splenic lymphoma with villous lymphocytes.
    Kanbay M; Selcuk H; Gur G; Dagli N; Karakus S; Yilmaz U
    Am J Hematol; 2006 Apr; 81(4):304-5. PubMed ID: 16550519
    [No Abstract]   [Full Text] [Related]  

  • 33. Hepatitis C virus infection in Taiwan: Past, present, and future.
    Kao JH
    J Formos Med Assoc; 2016 Feb; 115(2):65-6. PubMed ID: 26228687
    [No Abstract]   [Full Text] [Related]  

  • 34. Antiviral therapy of hepatitis C as curative treatment of indolent B-cell lymphoma.
    Merli M; Carli G; Arcaini L; Visco C
    World J Gastroenterol; 2016 Oct; 22(38):8447-8458. PubMed ID: 27784957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis C treatment gets into a new gear.
    Khokhar N
    J Coll Physicians Surg Pak; 2014 Dec; 24(12):879-81. PubMed ID: 25523720
    [No Abstract]   [Full Text] [Related]  

  • 36. Successful Treatment of HCV-associated B-Cell Non-Hodgkin Lymphomas With Direct-acting Antiviral Agents.
    de Clerck F; Geerts A; Brochez L; Speeckaert R; Boterberg T; Van Vlierberghe H; Verhelst X
    J Clin Gastroenterol; 2016; 50(5):438. PubMed ID: 26905607
    [No Abstract]   [Full Text] [Related]  

  • 37. Combination therapy for hepatitis C infection.
    Clay CM
    N Engl J Med; 1999 Apr; 340(15):1207; author reply 1208-9. PubMed ID: 10206842
    [No Abstract]   [Full Text] [Related]  

  • 38. Hepatitis C virus infection and antiviral treatment in marginal zone lymphomas.
    Arcaini L; Bruno R
    Curr Clin Pharmacol; 2010 May; 5(2):74-81. PubMed ID: 20156155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Future perspectives of hepatitis C therapeutics].
    Sakamoto N
    Hokkaido Igaku Zasshi; 2014 May; 89(1):13-15. PubMed ID: 25039102
    [No Abstract]   [Full Text] [Related]  

  • 40. Interferon for hepatitis C.
    Puoti C; Magrini A; Stati T; Rossi P; Montagnese F; Resta S
    Lancet; 1997 Feb; 349(9049):398-9. PubMed ID: 9033470
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.